OBSV stock

Obseva SA (NASDAQ:OBSV) fell 4%despite announcing that the US FDA had accepted its NDA for linzagolix for heavy menses bleeding

Biopharmaceutical company focusing on improving women’s health, ObsEva SA (NASDAQ:OBSV) and Organon , a global women’s health company on July